ZNF200
gene geneOn this page
Summary
ZNF200 (zinc finger protein 200, HGNC:12993) is a protein-coding gene on chromosome 16p13.3, encoding Zinc finger protein 200 (P98182). Localizes protein arginine N-methyltransferase PRMT3 to the nucleus.
Predicted to enable zinc ion binding activity. Involved in protein localization to nucleus. Located in nucleus.
Source: NCBI Gene 7752 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 77 total
- MANE Select transcript:
NM_198088
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12993 |
| Approved symbol | ZNF200 |
| Name | zinc finger protein 200 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000010539 |
| Ensembl biotype | protein_coding |
| OMIM | 603231 |
| Entrez | 7752 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 22 protein_coding, 3 retained_intron
ENST00000396868, ENST00000396870, ENST00000396871, ENST00000414144, ENST00000431561, ENST00000575285, ENST00000575617, ENST00000575630, ENST00000575948, ENST00000577015, ENST00000854056, ENST00000854057, ENST00000854058, ENST00000854059, ENST00000854060, ENST00000854061, ENST00000854062, ENST00000854063, ENST00000854064, ENST00000928466, ENST00000946755, ENST00000946756, ENST00000946757, ENST00000946758, ENST00000946759
RefSeq mRNA: 6 — MANE Select: NM_198088
NM_001145446, NM_001145447, NM_001145448, NM_003454, NM_198087, NM_198088
CCDS: CCDS10497, CCDS42112, CCDS45395
Canonical transcript exons
ENST00000414144 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000666495 | 3232421 | 3232547 |
| ENSE00000830612 | 3233506 | 3233836 |
| ENSE00001526551 | 3222325 | 3224613 |
| ENSE00001626515 | 3234987 | 3235158 |
| ENSE00003517262 | 3232833 | 3232921 |
Expression profiles
Bgee: expression breadth ubiquitous, 238 present calls, max score 94.97.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0288 / max 91.3627, expressed in 1754 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 156017 | 4.7915 | 1655 |
| 156016 | 1.7417 | 855 |
| 156015 | 1.4957 | 1007 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 94.97 | gold quality |
| oocyte | CL:0000023 | 92.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.52 | gold quality |
| sperm | CL:0000019 | 90.74 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.70 | gold quality |
| male germ cell | CL:0000015 | 88.56 | gold quality |
| right testis | UBERON:0004534 | 86.72 | gold quality |
| left testis | UBERON:0004533 | 86.13 | gold quality |
| testis | UBERON:0000473 | 85.62 | gold quality |
| blood | UBERON:0000178 | 84.59 | gold quality |
| granulocyte | CL:0000094 | 82.70 | gold quality |
| endothelial cell | CL:0000115 | 82.33 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 78.40 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 78.25 | gold quality |
| placenta | UBERON:0001987 | 77.69 | gold quality |
| ventricular zone | UBERON:0003053 | 77.48 | gold quality |
| cortical plate | UBERON:0005343 | 77.13 | gold quality |
| adrenal tissue | UBERON:0018303 | 76.82 | gold quality |
| spleen | UBERON:0002106 | 76.73 | gold quality |
| ganglionic eminence | UBERON:0004023 | 76.72 | gold quality |
| leukocyte | CL:0000738 | 76.58 | gold quality |
| periodontal ligament | UBERON:0008266 | 76.52 | silver quality |
| tibia | UBERON:0000979 | 76.49 | gold quality |
| monocyte | CL:0000576 | 76.00 | gold quality |
| mononuclear cell | CL:0000842 | 75.95 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 75.92 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.77 | gold quality |
| vermiform appendix | UBERON:0001154 | 75.72 | gold quality |
| parietal pleura | UBERON:0002400 | 74.93 | gold quality |
| pleura | UBERON:0000977 | 74.63 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.09 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
94 targeting ZNF200, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
Literature-anchored findings (GeneRIF, showing 1)
- ZNF200 is a novel binding partner of G9a. (PMID:17584299)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-89o9.6 | ENSDARG00000075639 |
| mus_musculus | Zfp65 | ENSMUSG00000071281 |
| drosophila_melanogaster | CG9609 | FBGN0030787 |
| caenorhabditis_elegans | WBGENE00009866 | |
| caenorhabditis_elegans | M04C9.4 | WBGENE00010859 |
| caenorhabditis_elegans | WBGENE00011710 | |
| caenorhabditis_elegans | WBGENE00012969 | |
| caenorhabditis_elegans | F57C9.4 | WBGENE00019011 |
| caenorhabditis_elegans | WBGENE00019589 | |
| caenorhabditis_elegans | WBGENE00022016 | |
| caenorhabditis_elegans | WBGENE00271744 |
Paralogs (2): ZNF532 (ENSG00000074657), KRBOX1 (ENSG00000240747)
Protein
Protein identifiers
Zinc finger protein 200 — P98182 (reviewed: P98182)
All UniProt accessions (2): P98182, I3L1E4
UniProt curated annotations — full annotation on UniProt →
Function. Localizes protein arginine N-methyltransferase PRMT3 to the nucleus.
Subunit / interactions. Interacts (via C-terminus) with PRMT3 (via zinc-finger); the interaction is direct and required to localize protein arginine N-methyltransferase PRMT3 to the nucleus and inhibit its proteasomal degradation.
Subcellular location. Nucleus.
Tissue specificity. Highly expressed in testis, weakly expressed in spleen, thymus, prostate, ovary, small intestine colon and peripheral blood leukocytes.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P98182-1 | 1 | yes |
| P98182-2 | 2 | |
| P98182-3 | 3 |
RefSeq proteins (6): NP_001138918, NP_001138919, NP_001138920, NP_003445, NP_932353, NP_932354* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (12 total): zinc finger region 5, splice variant 2, region of interest 2, chain 1, sequence variant 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P98182-F1 | 49.89 | 0.10 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 102 (showing top):
MORF_BRCA1, MORF_RAD51L3, YOKOE_CANCER_TESTIS_ANTIGENS, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, MODULE_397, MORF_BCL2L11, GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS, BROWNE_HCMV_INFECTION_14HR_UP, GEORGES_TARGETS_OF_MIR192_AND_MIR215, MORF_RFC5, MORF_IL16, MORF_ERCC4, MARTENS_TRETINOIN_RESPONSE_DN, HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP, ZHANG_RESPONSE_TO_CANTHARIDIN_DN
GO Biological Process (1): protein localization to nucleus (GO:0034504)
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein localization to organelle | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
630 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF200 | OR1F1 | O43749 | 854 |
| ZNF200 | EHMT2 | Q96KQ7 | 658 |
| ZNF200 | ZNF280A | P59817 | 595 |
| ZNF200 | MEFV | O15553 | 585 |
| ZNF200 | SLC22A3 | O75751 | 546 |
| ZNF200 | SLC22A2 | O15244 | 543 |
| ZNF200 | TIGD7 | Q6NT04 | 507 |
| ZNF200 | MED12 | Q93074 | 466 |
| ZNF200 | ZNF84 | P51523 | 462 |
| ZNF200 | ZNF382 | Q96SR6 | 453 |
| ZNF200 | ZNF668 | Q96K58 | 451 |
| ZNF200 | ZNF487 | B1APH4 | 444 |
| ZNF200 | FOSB | P53539 | 430 |
| ZNF200 | HEY1 | Q9Y5J3 | 429 |
| ZNF200 | ZNF738 | Q8NE65 | 392 |
| ZNF200 | RNF2 | Q99496 | 392 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FHL2 | ZNF200 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF200 | FHL2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF200 | TASOR2 | psi-mi:“MI:0915”(physical association) | 0.500 |
| ZNF200 | Dlg4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| CCL1 | ZNF200 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF200 | PPARGC1B | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF200 | SKIL | psi-mi:“MI:0915”(physical association) | 0.370 |
| ERH | BCLAF3 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF200 | ANXA13 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF200 | MDM2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (15): FAM208B (Affinity Capture-MS), FAM208B (Affinity Capture-MS), ZNF200 (Affinity Capture-RNA), ZNF200 (Synthetic Lethality), FHL2 (Two-hybrid), ZNF200 (Affinity Capture-MS), GABPA (Affinity Capture-MS), FAM208B (Affinity Capture-MS), ANXA13 (Affinity Capture-MS), ZNF200 (Affinity Capture-MS), MDM2 (Affinity Capture-MS), ZNF200 (Two-hybrid), PPARGC1B (Two-hybrid), ZNF200 (Affinity Capture-RNA), ZNF200 (Two-hybrid)
ESM2 similar proteins: A0A0A6YYL3, A0JP26, A2A2Z9, A2RUR9, A6NC57, A6NI47, A6QR20, A8MYB1, A9JSR5, A9ZSY0, B2RU33, B7ZQJ9, F1M5M3, H3BUK9, O15050, P51954, P98182, Q19UN5, Q4UJ75, Q501X2, Q5CZ79, Q5DW34, Q5SQ80, Q5TYW2, Q5VUR7, Q66HB6, Q6NSI1, Q6S545, Q6S5H5, Q6S8J7, Q71S21, Q7TPV2, Q7TSC3, Q7ZT11, Q80X59, Q811D2, Q86Y13, Q86YR6, Q8IVF6, Q8IYA2
Diamond homologs: B0X9H6, O15090, O60315, P98182, Q6IQX8, Q7TSH3, Q8K083, Q92618, Q9H4T2, Q9P2Y4, Q9R0G7, Q62255, Q6NX45, Q86T29, Q8CF60, Q96LX8, Q9BXA9, Q9ER74, Q9NSC2, Q9NX65, Q9UL36, A1YEV9, A1YG26, A1YG60, A2ANX9, A2T712, A2T736, A2T7L7, A3KN32, A7Y7X5, B0K011, E9Q6W4, O14771, O15391, O35738, O43474, O62836, O95125, P08048, P0CG23
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
995 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:3224611:CTG:C | acceptor_gain | 1.0000 |
| 16:3224614:C:CC | acceptor_gain | 1.0000 |
| 16:3232415:TCTTA:T | donor_loss | 1.0000 |
| 16:3232416:CTTA:C | donor_loss | 1.0000 |
| 16:3232417:TTACC:T | donor_loss | 1.0000 |
| 16:3232418:TA:T | donor_loss | 1.0000 |
| 16:3232419:A:AC | donor_gain | 1.0000 |
| 16:3232419:A:C | donor_loss | 1.0000 |
| 16:3232419:AC:A | donor_gain | 1.0000 |
| 16:3232420:C:CC | donor_gain | 1.0000 |
| 16:3232420:CC:C | donor_gain | 1.0000 |
| 16:3232545:CTC:C | acceptor_gain | 1.0000 |
| 16:3232546:TC:T | acceptor_gain | 1.0000 |
| 16:3232547:CC:C | acceptor_gain | 1.0000 |
| 16:3232548:C:CC | acceptor_gain | 1.0000 |
| 16:3232548:CT:C | acceptor_loss | 1.0000 |
| 16:3232828:CCCA:C | donor_loss | 1.0000 |
| 16:3232829:CCA:C | donor_loss | 1.0000 |
| 16:3232830:CA:C | donor_loss | 1.0000 |
| 16:3232831:A:AT | donor_loss | 1.0000 |
| 16:3232832:C:T | donor_loss | 1.0000 |
| 16:3232918:TGCA:T | acceptor_gain | 1.0000 |
| 16:3232919:GCA:G | acceptor_gain | 1.0000 |
| 16:3232920:CA:C | acceptor_gain | 1.0000 |
| 16:3232920:CAC:C | acceptor_gain | 1.0000 |
| 16:3232921:AC:A | acceptor_loss | 1.0000 |
| 16:3232922:C:CC | acceptor_gain | 1.0000 |
| 16:3232922:C:CG | acceptor_loss | 1.0000 |
| 16:3232923:T:A | acceptor_loss | 1.0000 |
| 16:3233505:CCT:C | donor_gain | 1.0000 |
AlphaMissense
2626 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:3224129:G:C | F317L | 1.000 |
| 16:3224129:G:T | F317L | 1.000 |
| 16:3224131:A:G | F317L | 1.000 |
| 16:3224213:G:C | F289L | 1.000 |
| 16:3224213:G:T | F289L | 1.000 |
| 16:3224215:A:G | F289L | 1.000 |
| 16:3224270:G:C | H270Q | 1.000 |
| 16:3224270:G:T | H270Q | 1.000 |
| 16:3224272:G:C | H270D | 1.000 |
| 16:3224297:A:C | F261L | 1.000 |
| 16:3224297:A:T | F261L | 1.000 |
| 16:3224299:A:G | F261L | 1.000 |
| 16:3223961:A:C | F373L | 0.999 |
| 16:3223961:A:T | F373L | 0.999 |
| 16:3223963:A:G | F373L | 0.999 |
| 16:3224045:G:C | F345L | 0.999 |
| 16:3224045:G:T | F345L | 0.999 |
| 16:3224047:A:G | F345L | 0.999 |
| 16:3224068:A:G | C338R | 0.999 |
| 16:3224090:A:C | H330Q | 0.999 |
| 16:3224090:A:T | H330Q | 0.999 |
| 16:3224102:A:C | H326Q | 0.999 |
| 16:3224102:A:T | H326Q | 0.999 |
| 16:3224104:G:C | H326D | 0.999 |
| 16:3224104:G:T | H326N | 0.999 |
| 16:3224112:C:G | R323P | 0.999 |
| 16:3224130:A:G | F317S | 0.999 |
| 16:3224152:A:G | C310R | 0.999 |
| 16:3224174:A:C | H302Q | 0.999 |
| 16:3224174:A:T | H302Q | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000144535 (16:3229527 C>A,T), RS1000326461 (16:3225056 T>C), RS1000502312 (16:3234448 G>A), RS1001046331 (16:3226130 G>A,C), RS1001072170 (16:3236807 G>C), RS1001083555 (16:3237072 A>C,G), RS1001379933 (16:3225779 C>T), RS1001539162 (16:3223469 G>C,T), RS1001690615 (16:3234678 G>A), RS1001747677 (16:3225525 T>C), RS1001967166 (16:3223589 CCA>C), RS1001983702 (16:3236729 A>G), RS1001988695 (16:3221920 A>T), RS1002009139 (16:3228033 A>C), RS1002256428 (16:3231932 G>A)
Disease associations
OMIM: gene MIM:603231 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | decreases expression, increases expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| Aflatoxin B1 | increases methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| motexafin gadolinium | decreases expression | 1 |
| clothianidin | decreases expression | 1 |
| abrine | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Adenine | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | increases expression, increases methylation | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Colchicine | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Etoposide | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Nickel | increases expression | 1 |
| Mitomycin | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.